NICOTINAMIDE ADENINE-DINUCLEOTIDE (NADH) - A NEW THERAPEUTIC APPROACH- PRELIMINARY-RESULTS WITH CANCER-PATIENTS AND PATIENTS WITH DEMENTIAOF THE ALZHEIMER-TYPE

Authors
BIRKMAYER JGD
Citation
Jgd. Birkmayer, NICOTINAMIDE ADENINE-DINUCLEOTIDE (NADH) - A NEW THERAPEUTIC APPROACH- PRELIMINARY-RESULTS WITH CANCER-PATIENTS AND PATIENTS WITH DEMENTIAOF THE ALZHEIMER-TYPE, Journal of tumor marker oncology, 10(1), 1995, pp. 71-78
Citations number
18
Categorie Soggetti
Oncology
Journal title
Journal of tumor marker oncology → ACNP
ISSN journal
08863849
Volume
10
Issue
1
Year of publication
1995
Pages
71 - 78
Database
ISI
SICI code
0886-3849(1995)10:1<71:NA(-AN>2.0.ZU;2-S
Abstract
The coenzyme nicotinamide adenine dinucleotide (NADH), also known as C oenzyme 1, was used in oral form to treat cancer patients with metasta ses. In all the 12 cases so far under observation for more than a year an improvement in their clinical status has been observed. NADH has a lso been given to patients with dementia of the Alzheimer type. They w ere treated with 10mg NADH tablets per day for 12 weeks. Significant i mprovement of the cognitive functions was observed.